Table 5. In-hospital parameters according to maximum NLR groups.
TVR: Target vessel revascularization; MACE: major adverse cardiac events; CRP: C-reactive protein; EF: ejection fraction; AF: atrial fibrillation; AV: atrioventricular; IABP: intra-aortic balloon pump; TIMI: thrombolysis in myocardial infarction; LMCA: left main coronary artery; LAD: left anterior descending coronary artery; C.X.: circumflex coronary artery; RCA: right coronary artery; PTCA: percutaneous transluminal coronary angioplasty; STENT: coronary stent; PTCA+STENT: percutaneous transluminal coronary angioplasty with stent.
| In-hospital parameters | Q1 (NLR<3.98) (n=160) | Q2 (NLR 3.98-5.95) (n=161) | Q3 (NLR 5.96-9.19) (n=160) | Q4 (NLR<9.19) (n=160) | p-value |
| Death | 0 (0%) | 2 (1.2%) | 4 (2.5%) | 15 (9.4%) | 0.001 |
| Reinfarction | 3 (1.9%) | 4 (2.5%) | 3 (1.9%) | 8 (5.0%) | 0.273 |
| TVR | 2 (1.3%) | 4 (2.5%) | 1 (0.6%) | 9 (5.6%) | 0.021 |
| MACE | 3 (1.9%) | 6 (3.8%) | 7 (4.4%) | 24 (15.0%) | 0.001 |
| Stroke | 0 (0%) | 0 (0%) | 2 (1.3%) | 0 (0%) | 0.110 |
| CRP | 0 (0%) | 3 (1.9%) | 3 (1.9%) | 30 (18.8%) | 0.001 |
| Dialysis | 0 (0%) | 0 (0%) | 3 (1.9%) | 2 (1.3%) | 0.141 |
| VT/VF | 5 (3.1%) | 13 (8.1%) | 11 (6.9%) | 39 (24.4%) | 0.001 |
| Heart Failure | 0 (0%) | 1 (0.6%) | 2 (1.3%) | 19 (11.9%) | 0.001 |
| Inotrope | 0 (0%) | 3 (1.9%) | 8 (5.0%) | 37 (23.1%) | 0.001 |
| Shock | 0 (0%) | 2 (1.3%) | 8 (5.0%) | 28 (17.5%) | 0.001 |
| IABP | 0 (0%) | 1 (0.6%) | 4 (2.5%) | 13 (8.1%) | 0.001 |
| EF; Mean ± SD | 47.84±7.43 | 46.21±7.80 | 44.47±8.51 | 42.78±9.59 | 0.001 |
| AF | 1 (0.6%) | 2 (1.2%) | 3 (1.9%) | 9 (5.6%) | 0.014 |
| AV block | 2 (1.3%) | 4 (2.5%) | 6 (3.8%) | 12 (7.5%) | 0.021 |
| Proximal Lesion | 101 (63.1%) | 109 (67.7%) | 101 (63.1%) | 112 (70.0%) | 0.470 |
| Temporary Pacemaker | 1 (0.6%) | 4 (2.5%) | 2 (1.3%) | 10 (6.3%) | 0.008 |
| GIS Bleeding | 1 (0.6%) | 0 (0%) | 1 (0.6%) | 5 (3.1%) | 0.036 |
| Groin Complication | 6 (3.8%) | 5 (3.1%) | 6 (3.8%) | 7 (4.4%) | 0.949 |
| Acute Thrombosis | 3 (1.9%) | 4 (2.5%) | 3 (1.3%) | 3 (1.3%) | 0.973 |
| Sub-Acute Thrombosis | 3 (1.9%) | 2 (1.2%) | 1 (0.6%) | 8 (5.0%) | 0.037 |
| Late Thrombosis | 0 (0%) | 0 (0%) | 3 (2.7%) | 0 (0%) | 0.031 |
| Transfusion | 2 (1.3%) | 0 (0%) | 2 (1.3%) | 9 (5.7%) | 0.002 |
| Post-mechanical | 0 (0%) | 2 (1.2%) | 0 (0%) | 0 (0%) | 0.113 |
| ARTERY | 0.416 | ||||
| LMCA | 0 (0%) | 1 (0.6%) | 0 (0%) | 1 (0.6%) | |
| LAD | 67 (41.9%) | 76 (47.2%) | 82 (51.3%) | 78 (48.8%) | |
| C.X. | 32 (20.0%) | 26 (16.1%) | 22 (13.8%) | 22 (13.8%) | |
| RCA | 61 (38.1%) | 56 (34.8%) | 56 (35.0%) | 58 (36.3%) | |
| Saphenous | 0 (0%) | 0 (0%) | 0 (0%) | 1 (0.6%) | |
| STROKE | 0 (0%) | 2 (1.2%) | 0 (0%) | 0 (0%) | |
| Number of Vessels | 0.593 | ||||
| 1 vessel | 89 (55.6%) | 83 (51.6%) | 86 (53.8%) | 75 (46.9%) | |
| 2 vessels | 48 (30.0%) | 54 (33.5%) | 44 (27.5%) | 54 (33.8%) | |
| 3 vessels | 23 (14.4%) | 24 (14.9%) | 29 (18.1%) | 31 (19.4%) | |
| 4 vessels | 0 (0%) | 0 (0%) | 1 (0.6%) | 0 (0%) | |
| Pre-PCI-TIMI | 0.313 | ||||
| 1 | 155 (96.9%) | 160 (99.4%) | 158 (98.8%) | 159 (99.4%) | |
| 2 | 4 (2.5%) | 1 (0.6%) | 2 (1.3%) | 0 (0%) | |
| 3 | 1 (0.6%) | 0 (0%) | 0 (0%) | 1 (0.6%) | |
| Pos-PCI-TIMI | 0.001 | ||||
| 1 | 0 (0%) | 5 (3.1%) | 5 (3.1%) | 8 (5.0%) | |
| 2 | 4 (2.5%) | 4 (2.5%) | 5 (3.1%) | 16 (10.0%) | |
| 3 | 156 (97.5%) | 152 (94.4%) | 150 (93.8%) | 136 (85.0%) | |
| Procedure | 0.415 | ||||
| PTCA | 26 (16.3%) | 32 (19.9%) | 38 (23.8%) | 35 (22.3%) | |
| STENT | 37 (23.1%) | 35 (21.7%) | 25 (15.6%) | 26 (16.6%) | |
| PTCA+STENT | 97 (60.6%) | 94 (58.4%) | 97 (60.6%) | 96 (61.1%) | |
| Conclusion | 0.001 | ||||
| Successful | 157 (98.1%) | 155 (96.9%) | 154 (96.9%) | 143 (89.4%) | |
| Unsuccessful | 3 (1.9%) | 5 (3.1%) | 5 (3.1%) | 17 (10.6%) |